TERN — TERNS PHARMACEUTICALS INC

Ownership history in STEMPOINT CAPITAL LP  ·  3 quarters on record

This page tracks every 13F SEC filing in which STEMPOINT CAPITAL LP reported a position in TERNS PHARMACEUTICALS INC (TERN). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
2.97% (2025 Q4)
Avg. % of fund
1.41%
First filed
2024 Q3
Last filed
2025 Q4
Quarters held
3
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 ADDED 429,198 +339,581 +378.9% 2.97% $17.3M $40.40
2025 Q3 REDUCED 89,617 -359,704 -80.1% 0.13% $673K $7.51
2024 Q3 INITIATED 449,321 — — 1.12% $3.7M $8.34
% of Fund (quarterly)    TERN price (monthly, adj. close)

Other funds also holding TERN

As of 2025 Q4 — sorted by position size

ACORN CAPITAL ADVISORS, LLC 23.9% ACUTA CAPITAL PARTNERS, LLC 3Y 7Y 17.48% Vivo Capital, LLC 3Y 7Y 13.96% SUPERSTRING CAPITAL MANAGEMENT LP 9.6% Vestal Point Capital, LP 6.18% Ikarian Capital, LLC 3Y 5.04% Monashee Investment Management LLC 3Y 7Y 4.49% First Turn Management, LLC 4.03% Commodore Capital LP 3Y 3.97% Patient Square Capital LP 3Y 2.77%
← Back to STEMPOINT CAPITAL LP Holdings